Oncology & Cancer

For patients with distant-stage cancers, there was an increase in early palliative care (PC) billing from 2010 to 2019, but the level remained low, according to a study published in the Journal of Clinical Oncology.

One of Australia’s most common gynecological cancers could be detected sooner and more accurately thanks to a specialized artificial intelligence (AI) model, new research shows.

New research shows that a combined effort of mailing stool-based tests and providing patient navigation to follow-up procedures significantly increased screenings for colorectal cancer (CRC) among Medicaid enrollees in rural areas.

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer Research and Director of the Vaccine and Cell Therapy Laboratory, have tested a promising new type of personalized multi-peptide neoantigen cancer vaccine, called PGV001, in a small group of patients.

Researchers have long known that diet exerts a profound influence on health, including the risk of developing cancer. A new study, led by researchers at Arizona State University, explores the relationship among diet, blood sugar (specifically glucose) and cancer prevalence across a broad range of vertebrate species.

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common type of malignant brain tumor in children—and potentially sparing young patients from unnecessary treatments and their harmful long-term side effects.

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic cancer respond to immunotherapies. The findings, which were recently published in the journal Cancer Research Communications, reinforce the need to include racially diverse participants in clinical studies.

A new PET radiotracer can effectively visualize Nectin-4, an emerging biomarker found in triple-negative breast cancer (TNBC). According to research published in the March issue of The Journal of Nuclear Medicine, the PET tracer has the potential to play a critical role in the diagnosis, treatment, and monitoring of this aggressive disease, improving clinical outcomes for patients.

A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with researchers from the Agency for Science, Technology and Research and Chinese Academy of Agricultural Sciences, has successfully developed a novel spatial immune-based hepatocellular carcinoma (HCC) recurrence risk prediction platform.

Every day, billions of cells in your body divide, helping to replace old and injured cells with new ones. And each time this happens, your entire genetic library—your genome, which totals more than 3 billion base pairs of DNA—has to be copied, precisely, from the parent cell to the new daughter cell.